Compositions and methods of treating cancer
OwnerHongyu Zhao, Qian Chen +1inventors
InventorsHongyu Zhao, Qian Chen, Guidong Zhu
Life of this patent
Estimating the term…
Abstract
The invention provides pharmaceutical compositions of caspase inhibitor(s), apoptosis inducer(s), and/or PD-1 pathway inhibitor(s), and methods for treating cancer and related diseases and conditions.
Claims24
A method for treating cancer, comprising intratumorally administering, simultaneously or sequentially, to a subject in need thereof a therapeutically effective amount of a caspase inhibitor and a therapeutically effective amount of an apoptosis inducer.
(canceled)
A method for treating cancer, comprising intratumorally administering to a subject in need thereof a therapeutically effective amount of emricasan, or a pharmaceutically acceptable form thereof.
(canceled)
22-27. (canceled)
A method for treating cancer, comprising subcutaneously administering to a subject in need thereof a therapeutically effective amount of emricasan, or a pharmaceutically acceptable form thereof, and intravenously administering to the subject a therapeutically effective amount of docetaxel, or a pharmaceutically acceptable form thereof.
29-41. (canceled)
Dependencies are inferred from the claim text.